Related Experiment Video
Updated: Aug 30, 2025

09:39
Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
Published on: July 29, 2016
15.5K
Myotonic dystrophy type 1 presenting with dyspnea: A case report
Yu-Xi Jia1,2, Chun-Ling Dong3, Jia-Wei Xue3
1Department of Orthopedics, The Second Hospital of Jilin University, Changchun 130041, Jilin Province, China.
World Journal of Clinical Cases
|September 2, 2022
Summary
Myotonic dystrophy type 1 (DM1) is a variable genetic neuromuscular disease. Early diagnosis of DM1 is crucial, as symptoms like dyspnea can be the first sign, improving patient quality of life.
Area of Science:
- Genetics
- Neuromuscular Disorders
- Pulmonology
Background:
- Myotonic dystrophy type 1 (DM1) is a multisystem genetic neuromuscular disorder.
- The variable clinical presentation of DM1 hinders early diagnosis and treatment.
- Cardiopulmonary involvement is a significant feature of DM1.
Observation:
- A 35-year-old female presented with dyspnea and sleep apnea as primary symptoms.
- Clinical examination revealed low limb muscle tension.
- Electromyography confirmed myotonia, and genetic testing identified CTG repeat expansion in the DMPK gene, confirming DM1.
Findings:
- DM1 diagnosis confirmed by genetic testing showing >50 CTG repeats in the DMPK gene.
- The patient's initial presentation was primarily respiratory, highlighting symptom variability.
- Electromyography demonstrated characteristic myotonia potentials.
Implications:
- Pulmonologists should consider DM1 in patients presenting with dyspnea.
- Improved clinician understanding of DM1 is essential for early diagnosis.
- Timely diagnosis of DM1 can significantly enhance patient quality of life.
Related Concept Videos
Disorders of the Skeletal Muscle
1.0K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.0K
Satellite Stem Cells and Muscular Dystrophy
2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
38
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
38
Cardiomyopathy II: Dilated Cardiomyopathy
19
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
19
Myasthenia Gravis: Diagnostic Tests
1.3K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.3K
Myasthenia Gravis: Overview and Treatment
1.8K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.8K

